Study: Lesion differences can determine MS treatment benefits

08/12/2005 | Yahoo!

Researchers have identified key distinctions in multiple sclerosis lesions that can indicate whether patients can benefit from a therapy called plasma exchange. Only those patients whose lesions include evidence of antibody deposition or immune cell activity called "complement activation" are likely to respond to the plasma exchange treatment for acute attacks, according to the study.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR